clinical development raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-11-04. Anything still debated is marked as such rather than presented as settled.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In general, drugs like suvomipic are only thought to have potential effectiveness for a given follicle if it is still intact, undamaged, and merely dormant. Hair follicles are known to undergo progressive damage from low-grade microinflammation and reduced blood flow in androgenic alopecia, resulting not only in dormancy but also in perifollicular fibrosis and associated follicular miniaturization. In addition, in more advanced or later-stage cases, there can be arrector pili muscle detachment and micro-scarring. These sequelae are thought to limit the potential for follicular regeneration.
=== Channel 5 === In 2010, Willis replaced Melinda Messenger on the Channel 5 series Live from Studio Five, but she left after only two months to co-present Big Brother's Little Brother and was replaced by Jayne Middlemiss. In August 2011, she returned to the revived series, presenting the spin-off show Big Brother's Bit on the Side. On 13 March 2013, it was reported that Brian Dowling would be axed from Big Brother and be replaced by Willis with a source saying, 'Brian has been a great host but Emma is seen by channel chiefs as a true successor to Davina. They're talking to her now about taking over the role from the summer.' Her appointment as host was confirmed on 2 April 2013. On 13 June 2013, she began presenting the fourteenth series of Big Brother. As well as presenting the main Big Brother and celebrity series, she continued to host the spin-off show Bit on the Side, sharing the presenting duties with Rylan Clark. On 2 February 2015, it was announced that Willis was to present her final edition of Bit on the Side that night, and Clark would take over as the main presenter of the spin off show. Willis interrogated Winston McKenzie during his exit interview on Celebrity Big Brother over his controversial opinions. Willis has expressed personal pride on this moment in her career. On 30 March 2014, Willis presented the Mum of the Year Awards, with the highlights being shown on Channel 5 that same evening.
=== Cancer === FcRn may influence the tumor microenvironment by modulating the fate of IgG and immune complexes, which play roles in tumor immunity and immune evasion. FcRn is expressed in certain tumor-associated cells, including tumor-infiltrating macrophages and dendritic cells, where it helps process IgG-bound antigens for presentation and clearance. Altered FcRn expression has been observed in some cancers and may correlate with immune escape or therapeutic resistance, especially in tumors treated with monoclonal antibodies. Moreover, FcRn-mediated recycling can affect the local persistence of therapeutic antibodies in tumor tissues, potentially impacting efficiency.
==== V-RG ==== RABORAL V-RG (Boehringer Ingelheim, Duluth, GA, USA) is a vaccinia virus (originally a smallpox vaccine) modified to express rabies glycoprotein. V-RG has been proven safe in over 60 animal species including cats and dogs. It is only approved for wildlife and sold to federal agencies. V-RG has been the only ORV licensed in the US for rabies virus management since 1997. V-RG baits consist of a small packet containing the oral vaccine which is then either coated in a fishmeal paste or encased in a fishmeal-polymer block.
The earliest efforts used methods similar to those used by Dayhoff, using large-scale matching of the protein database to generate a new log-odds matrix and the JTT (Jones-Taylor-Thornton) model. The rapid increases in compute power in the 21st century (reflecting factors such as Moore's law) made it feasible to estimate parameters for empirical models using maximum likelihood (e.g., the WAG and LG models) and other methods (e.g., the VT and PMB models). The IQ-Tree software package allows users to infer their own time reversible model using QMaker, or non-time-reversible using nQMaker. These methods produce both a tree and a best-fitting matrix. GTR is also available in IQ-Tree. The inference of custom models and GTR require a relatively large alignment due to the large number of parameters involved. As a consequence, a large number of empirical substitution models of protein evolution are currently available. These substitution models are derived from protein sequences of different taxonomic groups and protein families such as nuclear proteins, chloroplast proteins, mitochondrial proteins, and viral proteins, among others. A singular empirical model assume a constant set of amino acid frequencies over the entire evolutionary tree, which is often not the case over wide-spanning trees. The Bayesian CAT model was introduced in 2004. Maximum-likelihood version of it with 10–60 empirical profiles (C10–C60) were introduced in 2008. These methods are available in PhyML and IQ-TREE.
Sources: en.wikipedia.org
On October 17, 1952, Giáp launched attacks against the French garrisons along Nghĩa Lộ, northwest of Hanoi, and overran much of the Black River valley, except for the airfield of Nà Sản where a strong French garrison entrenched. Giáp by now had control over most of Tonkin beyond the De Lattre Line. Raoul Salan, seeing the situation as critical, launched Operation Lorraine along the Clear River to force Giáp to relieve pressure on the Nghĩa Lộ outposts. On October 29, 1952, in the largest operation in Indochina to date, 30,000 French Union soldiers moved out from the De Lattre Line to attack the Việt Minh supply dumps at Phú Yên. Salan took Phú Thọ on November 5, and Phu Doan on November 9 by a parachute drop, and finally Phú Yên on November 13. Giáp at first did not react to the French offensive. He planned to wait until their supply lines were overextended and then cut them off from the Red River Delta. Salan correctly guessed what the Việt Minh were up to and cancelled the operation on November 14, beginning to withdraw back to the De Lattre Line. The only major fighting during the operation came during the withdrawal, when the Việt Minh ambushed the French column at Chan Muong on November 17. The road was cleared after a bayonet charge by the Indochinese March Battalion, and the withdrawal could continue. The French lost around 1,200 men during the whole operation, most of them during the Chan Muong ambush. The operation was partially successful, proving that the French could strike out at targets outside the De Lattre Line.
In 1934, John Desmond Bernal and his student Dorothy Hodgkin discovered that protein crystals surrounded by their mother liquor (the remaining solution after a protein has crystallized out of a supersaturated solution) gave better diffraction patterns than dried crystals. Using pepsin, they were the first to discern the diffraction pattern of a wet, globular protein. Prior to Bernal and Hodgkin, protein crystallography had only been performed in dry conditions with inconsistent and unreliable results. This is the first X‐ray diffraction pattern of a protein crystal. In 1958, the structure of myoglobin (a red protein containing heme), determined by X-ray crystallography, was first reported by John Kendrew. Kendrew shared the 1962 Nobel Prize in Chemistry with Max Perutz for this discovery.
Routine toxicology studies have provided no evidence that moxonidine has any teratogenic, mutagenic or carcinogenic potential. No evidence has been found of serious adverse effects on organs or organ systems, and the drug has not been shown to have deleterious effects on perinatal or postnatal growth and development.
In Japan, public universities are run by local governments, either prefectural or municipal. According to the Ministry of Education, public universities have "provided an opportunity for higher education in a region and served the central role of intellectual and cultural base for the local community in the region" and are "expected to contribute to social, economical and cultural development in the region". This contrasts with the research-oriented aspects of national universities. In 2010, 127,872 students were attending 95 public universities, compared to 86 national universities and 597 private universities in Japan. Many public universities are relatively new; in 1980, there were only 34 public universities in Japan. Since July 2003, public universities may incorporate under the Local Independent Administrative Institutions Law.
== Epidemiology == Biliary atresia seems to affect females slightly more often than males, and Asians and African Americans more often than Caucasians. It is common for only one child in a pair of twins or within the same family to have the condition. There seems to be no link to medications or immunizations given immediately before or during pregnancy. Diabetes during pregnancy particularly during the first trimester seems to predispose to a number of distinct congenital abnormalities in the infant such as sacral agenesis, transposition of the great vessels and the syndromic form of biliary atresia.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.